InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Jones Andrew D., Chief Financial Officer. Insider active across 1 company, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 4 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €7k. History available since 4 May 2021. The latest transaction was filed on 3 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
8,690 shares@ US$0.440.0065% mcap3.1% of flowCommon StockSEC:0001437749-21-027933:0
Ideal exit: 30 Aug 2022 (T+270)
8,690 shares@ US$0.440.0065% mcap6.2% of flowCommon StockSEC:0001437749-21-027933
Ideal exit: 30 Aug 2022 (T+270)
77,994 shares@ US$0.79280.099% mcap46.9% of flowCommon StockSEC:0001437749-21-011378:0
77,994 shares@ US$0.792846.9% of flowCommon StockSEC:0001437749-21-011378
4 of 4 declarations
About Jones Andrew D.
Andrew D. Jones is the CFO at NovaBay Pharmaceuticals, Inc. In this role, he is responsible for the financial management of the company, including financial planning and risk management. His expertise is essential for ensuring the economic health of NovaBay.
